Free tool
Stocks near their 52-week high
We cover 116 companies trading within 5% of their own 52-week high. The median market value in the group is $6.06B. Across the group, the median move over the past trading day is 0.00%. 99% of the 112 with a 200-day average trade above it. Price change over the past year runs from +11.3% to +190.2% across the middle 80 percent of the group, with a median of +42.6%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
116 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +41.64% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.16B | Large cap | +33.80% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.08B | Large cap | +36.03% |
| C1AH34.SA | Cardinal Health, Inc. | $55.77B | Large cap | +52.41% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.19B | Large cap | +110.08% |
| A | Agilent Technologies, Inc. | $43.80B | Large cap | +31.46% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| WAT | Waters Corporation | $40.67B | Large cap | +40.57% |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.39B | Large cap | +57.62% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| D1EX34.SA | DexCom, Inc. | $33.75B | Large cap | +9.64% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% |
| DC4.DE | DexCom, Inc. | $33.35B | Large cap | +21.06% |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% |
| C1NC34.SA | Centene Corporation | $32.65B | Large cap | +116.61% |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +65.32% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% |
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +27.06% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% |
| ORNAV.HE | Orion Oyj | $13.11B | Large cap | +21.27% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +197.09% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% |
| RHCPA.AX | Ramsay Health Care Limited | $10.16B | Large cap | +1.45% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% |
| PYC.AX | PYC Therapeutics Limited | $1.60B | Small cap | +74.42% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.58B | Small cap | +298.89% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| 3148.T | Create SD Holdings Co., Ltd. | $1.38B | Small cap | +1.90% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | $1.08B | Small cap | +35.66% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| B2RK34.SA | Bruker Corporation | $906.52M | Small cap | +63.27% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% |
| AMS.L | Advanced Medical Solutions Group plc | $830.96M | Small cap | +38.01% |
| UU8.F | Neurogene Inc. | $795.50M | Small cap | +165.60% |
| 7575.T | Japan Lifeline Co., Ltd. | $694.70M | Small cap | +12.02% |
| GUD.TO | Knight Therapeutics Inc. | $690.78M | Small cap | +50.39% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| 6197.T | Solasto Corporation | $635.28M | Small cap | +136.68% |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% |
| 2664.T | Cawachi Limited | $531.16M | Small cap | +38.25% |
| 7979.T | Shofu Inc. | $517.24M | Small cap | +21.34% |
| 3151.T | Vital KSK Holdings, Inc. | $501.27M | Small cap | +40.44% |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% |
| FRX.TO | Fennec Pharmaceuticals Inc. | $429.52M | Small cap | +36.00% |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | $397.43M | Small cap | +27.04% |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% |
| LIK.DE | LIMES Schlosskliniken AG | $199.75M | Small cap | +70.66% |
| LOVE.TO | Cannara Biotech Inc. | $141.63M | Small cap | +11.80% |
| 4599.T | StemRIM | $140.21M | Small cap | +14.75% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.